<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">At present, the medical cannabis market is one of the fastest-growing and most perspective markets worldwide. As of 2019, it was estimated at $3.5 billion, and according to the 2025 forecast, a stable growth up to $20.2 billion is expected, with the compound annual growth rate (GAGR) index of 24.4% (Industry Research 
 <xref ref-type="bibr" rid="CR21">2019</xref>). By 2020, more than 50 countries have legalized cannabis and cannabinoids for medical purposes, including Canada, most of the US, Germany, Luxemburg, Switzerland, Uruguay, Australia, etc. In Ukraine, the process of national legislation liberalization concerning cannabis application for medical purposes is at a nascent stage. It is, therefore, appropriate to conduct a complex analysis of stakeholdersâ€™ targets, expectations and possible actions, evaluate opportunities and risks for this market and develop recommendations for suitable conditions for its sound development.
</p>
